Northwest Investment Counselors’s Vertex Pharmaceuticals VRTX Stock Holding History

Northwest Investment Counselors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$25.1K	Buy	+54	New	+$25.9K	0.01%	321
2024 Q2	–	Sell	-40	Closed	-$16.7K	–	493
2024 Q1	$16.7K	Buy	+40	New	+$16.9K	﹤0.01%	335
2023 Q4	–	Sell	-48	Closed	-$16.7K	–	527
2023 Q3	$16.7K	Hold	48	–	–	﹤0.01%	328
2023 Q2	$16.9K	Buy	48 +8	+20%	+$2.69K	﹤0.01%	333
2023 Q1	$12.6K	Hold	40	–	–	﹤0.01%	376
2022 Q4	$11.6K	Hold	40	–	–	﹤0.01%	384
2022 Q3	$12K	Hold	40	–	–	﹤0.01%	350
2022 Q2	$11K	Hold	40	–	–	﹤0.01%	350
2022 Q1	$10K	Hold	40	–	–	﹤0.01%	397
2021 Q4	$9K	Buy	+40	New	+$7.78K	﹤0.01%	376
2021 Q2	–	Sell	-40	Closed	-$9K	–	435
2021 Q1	$9K	Buy	+40	New	+$8.79K	﹤0.01%	379
2020 Q4	–	Sell	-40	Closed	-$11K	–	430
2020 Q3	$11K	Buy	+40	New	+$11K	﹤0.01%	319
2019 Q4	–	Sell	-40	Closed	-$7K	–	487
2019 Q3	$7K	Buy	+40	New	+$7.08K	﹤0.01%	405

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northwest Investment Counselors's VRTX Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2024: 54 shares worth $25.1K. The stake represents 0.01% of the portfolio and ranks #321 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in VRTX as recently as Q1 2024.

Northwest Investment Counselors first reported a position in VRTX in Q3 2019 and has held it in 13 quarters since. 1,545 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

Northwest Investment Counselors held 54 shares of Vertex Pharmaceuticals worth $25.1K as of Q3 2024.
Vertex Pharmaceuticals was a new Northwest Investment Counselors position in Q3 2024.
Vertex Pharmaceuticals made up 0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #321 holding.
Northwest Investment Counselors first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 13 quarters since.
1,545 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.